GlaxoSmithKline

Business • Health Care
Nine biopharmaceutical companies sign safety pledge for Covid-19 vaccine
Nine biopharmaceutical companies sign safety pledge for Covid-19 vaccine
Credit: unsplash.com/CDC

Nine biopharmaceutical companies have signed a safety pledge, committing to "developing and testing potential vaccines for COVID-19 in accordance with high ethical standards and sound scientific principles."

AstraZeneca, BioNTech, Moderna, Pfizer, Novavax, Sanofi, GlaxoSmithKline, Johnson & Johnson and Merck have signed the pledge just a week after the CDC's vaccine distribution plans surfaced, suggesting a vaccine would be available by as early as late October.

Regional News • Europe • United Kingdom
UK Government Secures 60m More Doses of COVID-19 vaccine
Glaxo Smith Kline Offices on the Great West Road at Brentford
Glaxo Smith Kline Offices on the Great West Road at Brentford Credit: Maxwell Hamilton / Wikimedia Commons (Creative Commons Attribution ShareAlike 3.0)

The UK government signed a deal with drug giants GSK and Sanofi for 60 million doses of an experimental COVID-19 vaccine. This is the country's fourth COVID-19 vaccination deal. The UK previously secured 100m doses from AstraZeneca and 90m doses from the alliance between Valneva, BioNtech and Pfizer.